In the TMA_2 cohort (Table 1), ccRCC patients with histologic grade 2 and 3 tumors more frequently had cyclin F-high expression (69.23%) than low expression (30.77%; p = 0.017). This evidence concerns the gene CCNF and nonpapillary renal cell carcinoma.